ARTES offers a range of vac­cine pro­duc­ing cell lines and process­es for out-licens­ing and tech­nol­o­gy trans­fer. All list­ed cell lines are based on our safe and high yield yeast expres­sion sys­tem Hansenu­la poly­mor­pha.

Avian Flupre-clin­i­cal PoC; based on METAVAX® VLP plat­form high­ly immuno­genic, adju­vant-free; cell line and process available
Hepati­tis Blicensed world­wide; new tech­nol­ogy with improved yield; RCB, USP, DSP IPC/QC pro­to­cols available
HPV
(L1‑6; ‑11; ‑16; ‑18)		RCB, USP, DSP IPC/QC pro­to­cols for the dif­fer­ent serotypes available

To obtain a quote, please con­tact us at info(at)artes-biotechnology.com indi­cat­ing name of the vac­cine of inter­est to you. We will revert to you with a ded­i­cat­ed offer spec­i­fy­ing deliv­ery times and costs.